Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS

RS Tedder, DC Shanson, DJ Jeffries… - The Lancet, 1984 - Elsevier
RS Tedder, DC Shanson, DJ Jeffries, R Cheingsong-Popov, A Dalgleish, P Clapham
The Lancet, 1984Elsevier
Antibodies reacting selectively with human T-cell leukaemia virus type I (HTLV-I) were
detected in approximately 5% patients with extended lymphadenopathy syndrome (ELAS)
and in less than 1% of unselected homosexual patients and drug abusers. None of 22
patients with acquired immunodeficiency syndrome (AIDS) had HTLV-I antibodies and
neither did 85 haemophiliacs and 940 blood donors. 3 out of 113 drug addicts had high
titres of antibodies to human T-cell leukaemia virus type II (HTLV-II). A T-cell line was …
Abstract
Antibodies reacting selectively with human T-cell leukaemia virus type I (HTLV-I) were detected in approximately 5% patients with extended lymphadenopathy syndrome (ELAS) and in less than 1% of unselected homosexual patients and drug abusers. None of 22 patients with acquired immunodeficiency syndrome (AIDS) had HTLV-I antibodies and neither did 85 haemophiliacs and 940 blood donors. 3 out of 113 drug addicts had high titres of antibodies to human T-cell leukaemia virus type II (HTLV-II). A T-cell line was derived from 1 of the seropositive ELAS patients. This line was found to be infected with, and releasing, HTLV-I. Infection by HTLV-I and HTLV-II retroviruses thus occurs more frequently in ELAS patients and drug addicts than in the UK population as a whole, but the low prevalence of these infections in ELAS and AIDS patients indicates that these two strains of lymphotropic retroviruses have no aetiological role in ELAS and AIDS.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果